Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 739, pseudogene (RNU6-739P) is a human gene classified as a processed RNA pseudogene located on chromosome 3 (3:64,511,755-64,511,857 on the positive strand)[1][3][5][7][9]. It is derived from the U6 small nuclear RNA, which is a component of the spliceosome essential for pre-mRNA splicing, but RNU6-739P itself does not produce a functional snRNA molecule. As with many pseudogenes, it is not known to encode a protein or to have a conserved, specific biological function. However, some pseudogenes, including noncoding RNA pseudogenes, may act as regulatory elements by sequestering microRNAs or interacting with other nucleic acid or protein molecules[2]. There are no direct links to diseases, biomarkers, drugs, or therapeutic targeting associated with RNU6-739P. It is not considered a therapeutic target, enzyme, receptor, transporter, or transcription factor, but is annotated as a noncoding pseudogene in major genomic databases[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 739, pseudogene (RNU6-739P).